StonvexLoading…
StonvexCore line items from SNDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 | Annual 2016 2016-12-31 |
|---|---|---|---|---|
Revenue | $1.54B | $4.98B | $4.38B | $4.05B |
Operating Income | Not available | $375.80M | $280.30M | $290.40M |
Net Income | Not available | $268.90M | $389.90M | $156.90M |
EPS (Diluted) | $0.23 | $1.52 | $2.28 | $1.00 |
Total Assets | Not available | $3.62B | $3.33B | $3.05B |
Total Liabilities | Not available | $1.49B | Not available | Not available |
Cash & Equivalents | Not available | $378.70M | $238.50M | $130.80M |
Free Cash Flow OCF − CapEx | Not available | $181.40M | $72.80M | $33.20M |
Shares Outstanding | Not available | 177.20M | 171.30M | 156.80M |